FORMULATION AND IN-VITRO EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF LORNOXICAM

被引：0
|
作者：
Kumar, P. Suresh [1 ]
Sravani, A. [1 ]
机构：
[1] Browns Coll Pharm, Dept Pharmaceut, Khammam 507305, Telangana, India
来源：
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH | 2020年 / 11卷 / 06期
关键词：
Lornoxicam; Guar gum; Xanthan gum; Carbopol; 934; Controlled release tablets; DRUG-DELIVERY;
D O I：
10.13040/IJPSR.0975-8232.11(6).2793-00
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The aim of the present study was to develop a controlled release formulation of Lornoxicam to maintain constant therapeutic levels of the drug for over 12 h. Guar gum, xantham gum, and carbopol 934 were employed as polymers. All the formulations were passed various physicochemical evaluation parameters, and they were found to be within limits. From the dissolution studies, it was evident that the formulation (F2) showed better and desired drug release patterns, i.e., 99.65% in 12 h. It contains the guar gum polymer. It followed the Higuchi order release kinetics mechanism.
引用
收藏
页码：2793 / 2800
页数：8
相关论文
共 50 条
  • [21] Preparation and In-Vitro Evaluation of Sustained Release Matrix Diclofenac Sodium Tablets Using HPMC KM 100 and Gums
    Iqbal, Zafar
    Khan, Raza
    Nasir, Fazli
    Khan, Jamshaid Ali
    Ahmad, Lateef
    Khan, Abad
    Shah, Yaser
    Dayo, Abdullah
    ARCHIVES OF PHARMACY PRACTICE, 2010, 1 (02) : 9 - 17
  • [22] Development and in vitro evaluation of a controlled release formulation to produce wide dose interval morphine tablets
    Holgado, M. A.
    Iruin, A.
    Alvarez-Fuentes, J.
    Fernandez-Arevalo, M.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 70 (02) : 544 - 549
  • [23] Development of the Composition and Technology for Controlled-Release Lornoxicam Tablets
    Son, A. V.
    Vainshtein, V. A.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2014, 48 (01) : 51 - 56
  • [24] Formulation Optimization and In-vitro and In-vivo Evaluation of Lornoxicam Ethosomal Gels with Penetration Enhancers
    Li, Keke
    Gao, Shanshan
    Tian, Baocheng
    Shi, Yanan
    Lv, Qingzhi
    Han, Jingtian
    CURRENT DRUG DELIVERY, 2018, 15 (03) : 424 - 435
  • [25] Formulation and evaluation of gastroretentive controlled release tablets of alfuzosin hydrochloride
    Math, Nijaguni Revansiddayya Rudraswamy
    Gupta, Vankdari Rama Mohan
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 28 (06) : 2147 - 2152
  • [26] Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation
    El-Ridy, Mohamed Shafik
    Yehia, Soad Aly
    Mohsen, Amira Mohamed
    El-Awdan, Sally A.
    Darwish, Asmaa Badawy
    CURRENT DRUG DELIVERY, 2018, 15 (01) : 122 - 133
  • [27] Effect of polymers on in-vitro performance of eplerenone sustained release matrix tablets
    Sunil, Reddy
    Katakam, Vinay
    Somagoni, Jagan Mohan
    Panakanti, Pavan
    Dharani, Sathish
    Yamsani, Madhusudan Rao
    ARCHIVES OF PHARMACY PRACTICE, 2012, 3 (03) : 223 - 228
  • [28] DEVELOPMENT AND IN-VITRO EVALUATION OF LIQUISOLID COMPACTS OF LORNOXICAM
    Patil, Shrishail S.
    Verma, Anant Singh
    Doddayya, Hiremath
    Udupi, R. H.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (05): : 2135 - 2146
  • [29] ASSESSMENT OF SUSTAINED RELEASE MATRIX TABLETS FOR QUETIAPINE FUMARATE: IN-VITRO STUDIES
    Urooj, Sadia
    Ali, Atif
    Khan, Hira
    Shah, Sajid Hussain
    Bin Asad, Muhammad Hassham Hassan
    Rasool, Fatima
    Khan, Muhammad Shoaib
    Akhtar, Naheed
    Wahaab, Abdul
    ACTA POLONIAE PHARMACEUTICA, 2018, 75 (01): : 107 - 117
  • [30] Design and in vitro evaluation of novel sustained-release matrix tablets for lornoxicam based on the combination of hydrophilic matrix formers and basic pH-modifiers
    Hamza, Yassin El-Said
    Aburahma, Mona Hassan
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2010, 15 (02) : 139 - 153
12345